Pharmacokinetics of dexmedetomidine in anaesthetized horses following repeated subcutaneous administration and intravenous constant rate infusion.
Authors: Di Cesare Federica, Rabbogliatti Vanessa, Draghi Susanna, Amari Martina, Brioschi Federica Alessandra, Villa Roberto, Ravasio Giuliano, Cagnardi Petra
Journal: BMC veterinary research
Summary
# Editorial Summary Dexmedetomidine has become increasingly valuable in equine anaesthesia protocols for its ability to enhance recovery quality and clinical outcomes, yet optimal dosing strategies during prolonged procedures remain unclear. Researchers compared the pharmacokinetic profiles of two administration routes in anaesthetised horses: repeated subcutaneous boluses of 2 µg/kg every 60 minutes versus intravenous constant rate infusion at 1 µg/kg/hour, monitoring drug accumulation and plasma concentrations throughout diagnostic procedures. The subcutaneous dosing regimen produced highly variable plasma concentrations with significant peak-and-trough fluctuations, whilst the CRI approach maintained more consistent therapeutic levels—a distinction with practical implications for maintaining stable anaesthetic depth and predictable recovery profiles during extended procedures. These findings suggest that CRI administration offers superior pharmacokinetic stability compared to intermittent bolusing, potentially reducing the risk of inadequate sedation or excessive accumulation in horses requiring prolonged anaesthesia. For practitioners developing balanced anaesthesia protocols, particularly for diagnostic procedures exceeding 120 minutes, consideration of constant rate infusion over repeated subcutaneous dosing may provide more reliable dexmedetomidine delivery and improved clinical outcomes.
Read the full abstract on PubMed
Practical Takeaways
- •Repeated subcutaneous dexmedetomidine administration every hour offers a practical non-IV alternative for maintaining sedation during equine diagnostic procedures under general anaesthesia
- •Both delivery methods improve recovery quality, so choice can be based on clinical circumstances and practitioner preference—IV CRI provides continuous infusion while SC allows interval dosing
- •Understanding the pharmacokinetics of these two routes helps optimize dosing schedules for better patient outcomes during equine surgical procedures
Key Findings
- •Dexmedetomidine repeated subcutaneous administration at 2 µg/kg every 60 minutes provides alternative delivery to intravenous constant rate infusion in anaesthetized horses
- •Both SC and IV CRI routes of dexmedetomidine administration improve clinical outcomes and recovery quality during balanced general anaesthesia
- •Pharmacokinetic profiles were established for dexmedetomidine SC dosing (2 µg/kg/60 min) versus IV CRI dosing (1 µg/kg/h) in equine anaesthesia